Bill Vasilko
About Bill Vasilko
Bill Vasilko serves as the Zone Business Director for Ultra Orphan Drug/Diseases at Travere Therapeutics, where he has worked since 2014. He has extensive experience in the pharmaceutical industry, particularly in managing sales teams and distributing therapies for ultra rare diseases.
Current Role at Travere Therapeutics
Bill Vasilko serves as the Zone Business Director for Ultra Orphan Drug/Diseases at Travere Therapeutics. He has held this position since 2014, overseeing operations in the Eastern Half of the United States. In this role, he focuses on the distribution of life-altering therapies for ultra rare diseases, aiming to impact both clinicians and patients positively.
Previous Experience in Pharmaceutical Sales
Bill Vasilko has a diverse background in pharmaceutical sales, having worked at several notable companies. He was a District Sales Manager at Luitpold Pharmaceuticals from 2011 to 2012. Prior to that, he served as Regional Sales Director at Genzyme for nine years, managing sales across multiple states including Pennsylvania and Ohio. His experience also includes roles at AstraZeneca and Centocor, where he specialized in cardiovascular sales.
Expertise in Ultra Orphan Drug Distribution
Vasilko has extensive experience in managing Clinical Account Managers across the Eastern United States, specifically focusing on the distribution of ultra orphan disease drugs. He is part of the original commercial team responsible for managing a portfolio of therapies for ultra rare diseases, including Rare Pediatric Liver Disease and Metabolic Genetics. His leadership has been instrumental in navigating the complexities of this specialized market.
Educational Background
Bill Vasilko studied at Slippery Rock University of Pennsylvania, where he earned a Bachelor of Science degree in Exercise Science from 1985 to 1989. He also attended Leechburg High School from 1979 to 1985, completing his secondary education before pursuing higher education.
Leadership and Training in Sales
Vasilko specializes in recruiting, hiring, and training sales representatives for ultra orphan disease therapies. His strong background in providing leadership and guidance within the ultra orphan disease drug distribution model has contributed to the effective management of sales teams and the successful implementation of therapeutic strategies.